Quoin Pharmaceuticals approves stock option award agreement forms under 2025 Equity Plan

Quoin Pharmaceuticals, Ltd.

Compensation Committee approved forms of Incentive and Non-Qualified Stock Option Award Agreements on Nov 14, 2025.
Awards are governed by the 2025 Equity Incentive Plan; exercise price can be paid via cash, broker-assisted sales, or cashless exercise.
Unvested options terminate upon employment cessation; vested options exercisable for up to 1 year after death/disability or 3 months after other termination.
All awards subject to clawback policy as per Plan Section 16.6; forfeited shares subject to transfer powers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.